VEGFA and breast cancer: In the MMTV‐PyMT model, it has been demonstrated elegantly that inhibition of the angiogenic switch 21, due to the loss of macrophages‐derived angiogenic factor VEGF 22, blocks lung metastasis of mammary tumors.